LifeStance Health Group, Inc. (NASDAQ: LFST), a provider of virtual and in-person outpatient mental health care, has priced a secondary offering of 22,250,000 shares at $12.35 per share. The offering, underwritten by Barclays, was filed with the Securities and Exchange Commission (SEC) on May 21, 2024, and became effective upon filing. The shares are expected to settle and close on or about September 11, 2026.
LifeStance Health Group operates across 33 states and in more than 550 centers, employing over 8,500 psychiatrists, advanced practice nurses, psychologists, and therapists. The company will not sell any shares or receive any proceeds from the main secondary offering; all proceeds will go to the selling stockholders. LifeStance has agreed to purchase 2,000,000 shares from the underwriter at the same price paid to the selling stockholders. This repurchase is contingent upon the completion of the offering and other customary conditions, though the offering itself does not depend on the repurchase.
